Vetcare

Vetcare is a Finnish pharmaceutical company specializing in the development, manufacturing, and marketing of innovative veterinary medicines and animal health products. Established in 1992, the company has evolved from a regional distributor into an international innovator with a focus on companion animals and livestock. Vetcare is best known for its proprietary R&D successes, including Sileo, the first FDA-approved treatment for noise aversion in dogs, and Zenalpha, a novel canine sedative. The company leverages strategic partnerships with global leaders like Zoetis and Dechra to distribute its proprietary products worldwide. Headquartered in Salo, Finland, Vetcare maintains a strong commitment to evidence-based medicine and improving animal welfare through pharmacological advancement. Their portfolio encompasses a wide range of therapeutic areas, including pain management, behavioral health, and anesthesia.